Classification Modeling to Identify Patients at Risk for Neurotoxicity and CRS Following Axicabtagene Ciloleucel (axi-cel) Treatment in 2nd Line R/R LBCL
MOLECULAR THERAPY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MOLECULAR THERAPY(2023)